pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Diagnostics Company · news · pharmadog
← back to Diagnostics Company
News · Diagnostics Company
94
stories
9h
2 Massachusetts biotechs call it quits
biospace
16h
Precision for All: Closing the gap between innovation and impact
biopharma dive
3d
Immunotherapy startup Adecto blames ‘risk-averse funding environment’ for closing down
fiercebiotech
3d
Abbott launches SimpleScreen CRC blood test in the US
fiercebiotech
4d
Roche launches simultaneous screening test for SMA, SCID and SCD
fiercebiotech
7d
Regenerative medicine needs more than stem cells
biospace
11d
Grail multicancer detection test wins FDA advisers’ backing
biopharma dive
11d
Grail survives adcomm vote as it awaits FDA decision for cancer blood test
fiercebiotech
12d
FDA adcomm votes in favor of benefit-risk of Grail’s cancer test
endpoints
12d
Pharmas face off for manufacturing talent amidst reshoring efforts
biospace
13d
Siemens Healthineers and Novo team up on fatty liver disease awareness, testing
fiercebiotech
14d
FDA offers little comment on Grail cancer test ahead of adcomm
endpoints
14d
Western licensing deals for Chinese radioligand therapies to jump in 2027, Sleuth forecasts
biospace
14d
Sleuth forecasts 2027 jump in Western license deals for Chinese radioligand therapies
biospace
14d
Telix buys ITM in bid to create a ‘radiopharmaceutical powerhouse’
biopharma dive
17d
FDA clears Aptitude’s latest Metrix molecular dx to test for COVID
fiercebiotech
20d
Convergence: Achieving representative enrollment in clinical trials
raps
20d
Convergence: Experts review the state of play for MDR/IVDR amid proposed reforms
raps
20d
Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure
fiercebiotech
20d
After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer
fiercebiotech
21d
Unlocking cell surface protein research with site-specific labeling
biospace
22d
J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg
fiercebiotech
22d
GE HealthCare mulls $1B imaging chemicals maker deal: Financial Times
fiercebiotech
24d
Definium LSD drug goes 3 for 3 with another pivotal anxiety trial win
fiercebiotech
26d
Labcorp snaps up MLM Medical Labs to boost laboratory footprint
fiercebiotech
28d
Guardant wins FDA nod for diagnostic guiding use of AstraZeneca’s Etcamah
fiercebiotech
Sep 3, 26
Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout
fiercebiotech
Sep 1, 26
Medtronic recalls reflux monitoring device as 184 serious injuries linked to capsule
fiercebiotech
Sep 1, 26
Boston Scientific halts sales of angiographic catheters amid 2 serious injuries
fiercebiotech
Aug 31, 26
Opinion: The most shocking thing about the latest statistics on CTE in football is that we find them so shocking
stat
← prev
page 1 of 4
next →
